đź’¨ Abstract
AC Immune SA, a Swiss biopharmaceutical company, reported a loss of $21.2 million and 21 cents per share in Q1 2025, with revenue of $1.1 million. The company's shares closed at $1.70, down from $2.40 a year ago. This news was generated by Automated Insights using data from Zacks Investment Research.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
PHOTO COLLECTION: Trump Immigration -
6 Ways to Make Sustainability A Part of Your Monthly Budget -
High court reinstates enforcement of Ohio’s ban on gender-affirming care for minors during appeal -
Calendario de partidos de la Copa Mundial de Beach Soccer de la FIFA por Universo
Rodolfo Aguiar: “El conflicto social está creciendo y es imparable” -
Southeast DC residents skeptical of new stadium plans in Ward 7 -
Meet David Corenswet, cinema’s new Superman -
First accuser resumes testimony at Harvey Weinstein’s #MeToo retrial -
Giannis Antetokounmpo enters this offseason with a big question awaiting him. Stay or go? -
Nottingham Forest owner steps back from control of Premier League club -
Powered by MessengerX.io